CEACAM5 and colorectal carcinoma: In our present study, we assessed MIC-1 as a serum biomarker for detection of CRC and demonstrated that serum MIC-1 can contribute to improve the performance of CEA for detecting CRC patients, complementing its capacity when offered to CEA negative individuals.